Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2019 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM® Biotechnologies Nutraceutical Division Announces Cannabinoid-Based Wellness Gum Product Line at Benzinga Cannabis Capital Conference

NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech,” “AXIM” or “the Company”) (OTCQB: AXIM), a world leader in cannabinoid research and development, announced...
May 09, 2019 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today announced...
April 23, 2019 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM® Biotechnologies, Inc. Nutraceutical Division Receives Purchase Order for 50,000 Boxes of the Company’s Proprietary CBD-Based Chewing Gum

NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today...
March 01, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech Announces the Production of CanChew Plus™, the Next Generation Controlled Release CBD Chewing Gum

NEW YORK, March 01, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, began production of CanChew Plus™, the next...
February 25, 2016 09:00 ET | Source: Medical Marijuana Inc

Medical Marijuana, Inc. Investment – AXIM Biotech – Lays Out Powerhouse IP Pipeline, Cannabinoid R&D in Interview

SAN DIEGO, Feb. 25, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to the public and its shareholders that its portfolio investment, AXIM® Biotechnologies,...